--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Aglan ABG" developer_entity: "Alpha Ralph LLC" bundle_id: "abg.app.com" app_store_id: "6449719279" google_play_id: "com.abg.app" category: "Medical" primary_platform: "ios" primary_monetization: "Free" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2025-10-23" report_date: "2026-09-30" last_verified: "2026-09-30T00:00:00.000Z" report_version: "1.0" total_reviews: 0 sentiment: "Thrilled" sentiment_score: 90 confidence: "medium" confidence_score: 0.4 top_praise_theme: "High accuracy and conclusive results provide users with reliable data output for their specific needs" review_sample_size: 2 total_review_count: 2 analyzed_review_count: 2 data_age_days: 7 momentum_velocity: "zombie" intelligence_version: 2 tags: ["medical", "free", "thrilled sentiment", "mobile app", "app review", "app analysis", "healthcare", "professionals", "requiring"] canonical_url: "https://marlvel.ai/apps/aglan-abg" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Aglan ABG Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Free - **Signal**: Sentiment Thrilled - **Recent focus**: High accuracy and conclusive results provide users with reliable data output for their specific needs (top praise) > **TL;DR:** Aglan ABG is a medical app by Alpha Ralph LLC, with Thrilled user sentiment (90/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** Aglan ABG is a medical app by Alpha Ralph LLC. ## Quick Facts | Fact | Value | | :--- | :--- | | **User Mood** | Thrilled | | **Category** | Medical | | **Developer** | Alpha Ralph LLC | | **Pricing** | Free | | **Platforms** | iOS & Android | | **Confidence** | Medium (0.4/1.0) | | **Data Age** | 7d | ## Metadata & Market Performance - **Publisher:** Alpha Ralph LLC - **Category:** Medical - **Target Audience:** Healthcare professionals requiring diagnostic tools for monitoring patient respiratory function and acid-base balance. - **Platforms:** iOS & Android - **Version Reviewed:** 1.0 - **Report Date:** 2026-09-30 - **Signal Count:** 2 reviews analyzed - **Confidence:** Medium (0.4/1.0) - **App Store ID (iOS):** 6449719279 - **Bundle ID:** abg.app.com - **Google Play ID:** com.abg.app - **Data Window:** Analysis based on signals collected up to 2026-09-30 ## Executive Snapshot **What it is:** Aglan ABG is a medical diagnostic tool for healthcare professionals to monitor respiratory function and acid-base balance on iOS and Android. **Why users hire it:** The application removes the manual calculation friction for clinicians assessing pO2, pCO2, and pH levels during patient care. ## App DNA (Features & Intent) - **[Basic] ABG Analysis:** Calculates oxygenation (pO2), carbon dioxide tension (pCO2), and pH levels for respiratory function assessment. - **[Standard] Trend Monitoring:** Tracks respiratory function changes over time to identify clinical trends. * *User Intent:* Users want visibility into their own performance and progress. ## Market Position {#market-position} Aglan ABG occupies a niche medical utility space with zero public ratings across both platforms. The lack of recent development activity (341 days since the last update) positions the tool as a legacy utility rather than an active competitor. ## Monetization Strategy - **Model:** Free - **Tiers:** Free - **Analysis:** The application is currently offered as a free tool with no observable in-app purchases or subscription tiers. ## 🟢 User Sentiment (Medium Confidence: 2 of 2 reviews analyzed) {#user-sentiment} - **Overall Sentiment:** Thrilled ### Top Praises - **High accuracy and conclusive results provide users with reliable data output for their specific needs** - **The interface design allows for straightforward navigation and ease of use during daily tasks** ## SWOT Analysis {#swot} **Core Strengths:** - Clinical-grade diagnostic output provides conclusive data for respiratory assessment - Simplified workflow design reduces cognitive load during daily clinical tasks **Growth Levers:** - Integration of automated PDF report generation would address the lack of documentation features ## What's New - **Latest (v2.0.0, 11 months ago):** Release notes contain no functional details or feature descriptions. ## App Momentum (Zombie) {#momentum} - Dormant for eleven months - Zero public ratings > **Cadence:** 2 total versions · 1 majors in last 6 months · 341 days since last update · 624 days avg between updates ## The "So What?" (Strategic Takeaway) {#so-what} Aglan ABG is a medical app that is completely free. > **Bottom Line:** Aglan ABG provides a functional diagnostic utility, but the lack of updates since late 2025 creates a trust deficit that prevents adoption in high-stakes clinical environments. **Best for:** Healthcare professionals requiring diagnostic tools for monitoring patient respiratory function and acid-base balance. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Ship a stability-focused update because the current eleven-month dormancy signals abandonment to clinical users → restore professional trust ### Outlook: Declining Users report: The medical diagnostic tool market increasingly favors applications with active, transparent update cycles that guarantee data accuracy. Aglan ABG remains exposed due to its stagnant release cadence, which will likely lead to further user churn as clinicians migrate to more actively maintained alternatives. - 🔴 The eleven-month development silence creates a perception of abandonment, which erodes the professional trust required for clinical diagnostic tools. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Total Reviews | 0 | | Sentiment | Thrilled (90/100) | | Confidence | Medium | | Pricing Model | Free | | Platforms | iOS & Android | | Key Features | 2 analyzed | | Outlook | Declining | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Aglan ABG** (this app) | N/A/5 | Thrilled | Alpha Ralph LLC | | [VetCore: Pet Health Records](https://marlvel.ai/apps/vetcore-pet-health-records) | N/A/5 | N/A | Dmitriy Motorin | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | ## Company Profile - **Developer:** Alpha Ralph LLC - **Website:** [https://ahmedaglan.com/privacy.html](https://ahmedaglan.com/privacy.html) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/aglan-abg/id6449719279?uo=4) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.abg.app&hl=en&gl=us) - **Dev Site:** [Official Website](https://ahmedaglan.com/privacy.html) - **Sources:** Developer website content, App store metadata, User reviews. ## Related Intel Reports - [*VetCore: Pet Health Records*](https://marlvel.ai/apps/vetcore-pet-health-records) (Dmitriy Motorin) · N/A Rating - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*101 Last Minute Study Tips*](https://marlvel.ai/apps/101-last-minute-study-tips) (Limmer Creative) · 3.4/5 Rating - [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.4/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 2 - **Data Sources:** user reviews, developer website, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 7 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/aglan-abg) Data licensed for AI Agent attribution under CC-BY-NC 4.0.